Dentsply Sirona’s second quarter results were met with a negative market reaction, as shares declined following revenue and non-GAAP earnings that exceeded Wall Street expectations. Management attributed the year-on-year revenue decline primarily to lower sales volumes in key product segments and regions, especially in the Americas and EMEA, and highlighted ongoing challenges in capital equipment demand and inventory reduction by distributor partners. CEO Daniel Scavilla described the company’s current phase as a “turnaround,” noting that while some parts of the business are stabilizing, improvement remains uneven across segments and geographies. The impact of tariff refunds also influenced quarterly profitability, but underlying operational momentum was mixed.
Is now the time to buy XRAY? Find out in our full research report (it’s free for active Edge members).
Dentsply Sirona (XRAY) Q2 CY2026 Highlights:
- Revenue: $898 million vs analyst estimates of $892.6 million (4.1% year-on-year decline, 0.6% beat)
- Adjusted EPS: $0.52 vs analyst estimates of $0.35 (50.1% beat)
- Adjusted EBITDA: $190 million vs analyst estimates of $146.8 million (21.2% margin, 29.4% beat)
- The company reconfirmed its revenue guidance for the full year of $3.55 billion at the midpoint
- Management reiterated its full-year Adjusted EPS guidance of $1.45 at the midpoint
- Operating Margin: 9.1%, up from -13.7% in the same quarter last year
- Market Capitalization: $2.27 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Dentsply Sirona’s Q2 Earnings Call
- Elizabeth Anderson (Evercore ISI) asked about the readiness of the executive team and the timing for EPS improvement; CEO Daniel Scavilla stressed that while the team is now complete, most benefits from recent hires and dealer additions will be seen in the fourth quarter and next year.
- Allen Lutz (Bank of America) sought specifics on which parts of the return-to-growth plan are showing the most promise; Scavilla highlighted increased clinician engagement and positive feedback from education programs, but noted that tangible P&L impact is expected to build gradually.
- Dylan Finley (Leerink Partners) inquired about the effect of tariff refunds on guidance and the run-rate for tariffs in COGS; Scavilla clarified that refunds were not embedded in guidance and that ongoing tariff costs are treated separately from operational results.
- Anton (BMO, for Vic Chopra) questioned U.S. commercial team buildout and whether productivity gains are factored into guidance; Scavilla indicated that while recent hires and training will drive efficiency, most impact will be realized in 2027 rather than this year.
- Lilia-Celine Lozada (JPMorgan) asked about the drivers behind softness in the OIS segment and the influence of macro trends; Scavilla attributed OIS weakness to the impact of Byte and U.S.-specific factors, reiterating that broader macroeconomic pressures are being absorbed for now.
Catalysts in Upcoming Quarters
Looking forward, our analyst team will watch (1) the pace at which new dealer partnerships and salesforce investments translate into higher sales, particularly in the U.S. and APAC, (2) stabilization of inventory levels at European distributors and any rebound in capital equipment demand, and (3) the progress of digital platform adoption and regulatory milestones for new product launches. Execution in these areas will be critical to Dentsply Sirona’s turnaround trajectory.
Dentsply Sirona currently trades at $11.51, down from $13.17 just before the earnings. Is there an opportunity in the stock? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
